Ercole Tagliamonte
About
In The Last Decade
Ercole Tagliamonte
20 papers receiving 276 citations
Peers
Comparison fields: 5 of 47
- Cardiology and Cardiovascular Medicine 227
- Radiology, Nuclear Medicine and Imaging 107
- Surgery 61
- Pulmonary and Respiratory Medicine 36
- Epidemiology 34
Countries citing papers authored by Ercole Tagliamonte
This map shows the geographic impact of Ercole Tagliamonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ercole Tagliamonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ercole Tagliamonte more than expected).
Fields of papers citing papers by Ercole Tagliamonte
This network shows the impact of papers produced by Ercole Tagliamonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ercole Tagliamonte. The network helps show where Ercole Tagliamonte may publish in the future.
Co-authorship network of co-authors of Ercole Tagliamonte
This figure shows the co-authorship network connecting the top 25 collaborators of Ercole Tagliamonte. A scholar is included among the top collaborators of Ercole Tagliamonte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ercole Tagliamonte. Ercole Tagliamonte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 13 | |
| 6 | 16 | |
| 7 | 4 | |
| 8 | 19 | |
| 9 | 38 | |
| 10 | 28 | |
| 11 | 54 | |
| 12 | 28 | |
| 13 | 32 | |
| 14 | [Efficacy of diltiazem in uremic hemodialyzed patients with isolated diastolic dysfunction and dialysis hypotensive crisis]. | 3 |
| 15 | [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan]. | 3 |
| 16 | [Incremental doses of diltiazem in patients with coronary artery disease in end-stage renal failure maintained on hemodialysis: which is the optimal dose?]. | 3 |
| 17 | [Syndrome X and microvascular angina]. | 4 |
| 18 | [Complex ventricular arrhythmias and carvedilol: efficacy in hemodialyzed uremic patients]. | 7 |
| 19 | [Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic cardiopathy in dialysis treatment]. | 3 |
| 20 | [Acute hepatitis following amiodarone administration]. | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.